Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells
- PMID: 10201372
- DOI: 10.1038/18884
Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells
Abstract
Mutations in the adenomatous polyposis coli (APC) tumour-suppressor gene occur in most human colon cancers. Loss of functional APC protein results in the accumulation of beta-catenin. Mutant forms of beta-catenin have been discovered in colon cancers that retain wild-type APC genes, and also in melanomas, medulloblastomas, prostate cancer and gastric and hepatocellular carcinomas. The accumulation of beta-catenin activates genes that are responsive to transcription factors of the TCF/LEF family, with which beta-catenin interacts. Here we show that beta-catenin activates transcription from the cyclin D1 promoter, and that sequences within the promoter that are related to consensus TCF/LEF-binding sites are necessary for activation. The oncoprotein p21ras further activates transcription of the cyclin D1 gene, through sites within the promoter that bind the transcriptional regulators Ets or CREB. Cells expressing mutant beta-catenin produce high levels of cyclin D1 messenger RNA and protein constitutively. Furthermore, expression of a dominant-negative form of TCF in colon-cancer cells strongly inhibits expression of cyclin D1 without affecting expression of cyclin D2, cyclin E, or cyclin-dependent kinases 2, 4 or 6. This dominant-negative TCF causes cells to arrest in the G1 phase of the cell cycle; this phenotype can be rescued by expression of cyclin D1 under the cytomegalovirus promoter. Abnormal levels of beta-catenin may therefore contribute to neoplastic transformation by causing accumulation of cyclin D1.
Similar articles
-
Regulation of cyclooxygenase-2 expression by the Wnt and ras pathways.Cancer Res. 2003 Feb 1;63(3):728-34. Cancer Res. 2003. PMID: 12566320
-
Beta- and gamma-catenin mutations, but not E-cadherin inactivation, underlie T-cell factor/lymphoid enhancer factor transcriptional deregulation in gastric and pancreatic cancer.Cell Growth Differ. 1999 Jun;10(6):369-76. Cell Growth Differ. 1999. PMID: 10392898
-
beta-Catenin regulates vascular endothelial growth factor expression in colon cancer.Cancer Res. 2003 Jun 15;63(12):3145-53. Cancer Res. 2003. PMID: 12810642
-
The Yin-Yang of TCF/beta-catenin signaling.Adv Cancer Res. 2000;77:1-24. doi: 10.1016/s0065-230x(08)60783-6. Adv Cancer Res. 2000. PMID: 10549354 Review.
-
TCF/LEF factor earn their wings.Trends Genet. 1997 Dec;13(12):485-9. doi: 10.1016/s0168-9525(97)01305-x. Trends Genet. 1997. PMID: 9433138 Review.
Cited by
-
β-Catenin knockdown in liver tumor cells by a cell permeable gamma guanidine-based peptide nucleic acid.Curr Cancer Drug _targets. 2013 Oct;13(8):867-78. doi: 10.2174/15680096113139990081. Curr Cancer Drug _targets. 2013. PMID: 23822752 Free PMC article.
-
Biflavone Ginkgetin, a Novel Wnt Inhibitor, Suppresses the Growth of Medulloblastoma.Nat Prod Bioprospect. 2015 Mar 29;5(2):91-7. doi: 10.1007/s13659-015-0056-4. Online ahead of print. Nat Prod Bioprospect. 2015. PMID: 25821199 Free PMC article.
-
Wnt3 function in the epiblast is required for the maintenance but not the initiation of gastrulation in mice.Dev Biol. 2013 Feb 1;374(1):164-73. doi: 10.1016/j.ydbio.2012.10.013. Epub 2012 Oct 16. Dev Biol. 2013. PMID: 23085236 Free PMC article.
-
Characterisation of colonic dysplasia-like epithelial atypia in murine colitis.World J Gastroenterol. 2016 Oct 7;22(37):8334-8348. doi: 10.3748/wjg.v22.i37.8334. World J Gastroenterol. 2016. PMID: 27729740 Free PMC article.
-
Quantitative Proteomics Reveals the Essential Roles of Stromal Interaction Molecule 1 (STIM1) in the Testicular Cord Formation in Mouse Testis.Mol Cell Proteomics. 2015 Oct;14(10):2682-91. doi: 10.1074/mcp.M115.049569. Epub 2015 Jul 21. Mol Cell Proteomics. 2015. PMID: 26199344 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous